Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.85−0.07 (-0.54%)
Close on Nov 17, 2026Market cap $171.97MP/E –Yield –
Anika Therapeutics cash
Cash and short-term investments held at the end of each period.
Anika Therapeutics's cash was $38.41M at Jun 30, 2026. For fiscal 2025 it was $81.17M, up 2.5% from the year before. Over ten years it grew -5.2% a year on average. The highest annual figure on record is $184.94M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.17M | +2.5% |
| FY2024 | Dec 31, 2024 | $79.22M | -16.7% |
| FY2023 | Dec 31, 2023 | $95.10M | -21.4% |
| FY2022 | Dec 31, 2022 | $120.95M | -2.6% |
| FY2021 | Dec 31, 2021 | $124.23M | +26.4% |
| FY2020 | Dec 31, 2020 | $98.32M | -46.8% |
| FY2019 | Dec 31, 2019 | $184.94M | +16.3% |
| FY2018 | Dec 31, 2018 | $159.01M | +1.1% |
| FY2017 | Dec 31, 2017 | $157.26M | +26.0% |
| FY2016 | Dec 31, 2016 | $124.76M | -9.9% |
| FY2015 | Dec 31, 2015 | $138.46M | +29.5% |
| FY2014 | Dec 31, 2014 | $106.91M | +68.8% |
| FY2013 | Dec 31, 2013 | $63.33M | +43.7% |
| FY2012 | Dec 31, 2012 | $44.07M | +23.2% |
| FY2011 | Dec 31, 2011 | $35.78M | +26.9% |
| FY2010 | Dec 31, 2010 | $28.20M | +15.5% |
| FY2009 | Dec 31, 2009 | $24.43M | -43.4% |
| FY2008 | Dec 31, 2008 | $43.19M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $38.41M | -50.2% |
| Q1 FY2026 | Mar 31, 2026 | $66.79M | -11.4% |
| Q4 FY2025 | Dec 31, 2025 | $81.17M | +2.5% |
| Q3 FY2025 | Sep 30, 2025 | $80.18M | -11.6% |
| Q2 FY2025 | Jun 30, 2025 | $77.12M | -20.2% |
| Q1 FY2025 | Mar 31, 2025 | $75.36M | -25.2% |
| Q4 FY2024 | Dec 31, 2024 | $79.22M | -16.7% |
| Q3 FY2024 | Sep 30, 2024 | $90.73M | -13.9% |
| Q2 FY2024 | Jun 30, 2024 | $96.60M | -5.1% |
| Q1 FY2024 | Mar 31, 2024 | $100.71M | -8.8% |
| Q4 FY2023 | Dec 31, 2023 | $95.10M | -21.4% |
| Q3 FY2023 | Sep 30, 2023 | $105.33M | -13.6% |
| Q2 FY2023 | Jun 30, 2023 | $101.81M | -17.6% |
| Q1 FY2023 | Mar 31, 2023 | $110.37M | -7.8% |
| Q4 FY2022 | Dec 31, 2022 | $120.95M | -2.6% |
| Q3 FY2022 | Sep 30, 2022 | $121.95M | +34.0% |
| Q2 FY2022 | Jun 30, 2022 | $123.56M | +27.1% |
| Q1 FY2022 | Mar 31, 2022 | $119.64M | +26.5% |
| Q4 FY2021 | Dec 31, 2021 | $124.23M | +26.4% |
| Q3 FY2021 | Sep 30, 2021 | $90.98M | -27.1% |
| Q2 FY2021 | Jun 30, 2021 | $97.18M | -32.7% |
| Q1 FY2021 | Mar 31, 2021 | $94.60M | +2.5% |
| Q4 FY2020 | Dec 31, 2020 | $98.32M | -46.8% |
| Q3 FY2020 | Sep 30, 2020 | $124.76M | -28.0% |
| Q2 FY2020 | Jun 30, 2020 | $144.37M | +2.1% |
| Q1 FY2020 | Mar 31, 2020 | $92.29M | -44.7% |
| Q4 FY2019 | Dec 31, 2019 | $184.94M | +16.3% |
| Q3 FY2019 | Sep 30, 2019 | $173.21M | +16.2% |
| Q2 FY2019 | Jun 30, 2019 | $141.45M | +1.5% |
| Q1 FY2019 | Mar 31, 2019 | $166.74M | +2.3% |
| Q4 FY2018 | Dec 31, 2018 | $159.01M | +1.1% |
| Q3 FY2018 | Sep 30, 2018 | $149.01M | -2.4% |
| Q2 FY2018 | Jun 30, 2018 | $139.30M | -2.5% |
| Q1 FY2018 | Mar 31, 2018 | $163.05M | +17.6% |
| Q4 FY2017 | Dec 31, 2017 | $157.26M | +26.0% |
| Q3 FY2017 | Sep 30, 2017 | $152.71M | +26.9% |
| Q2 FY2017 | Jun 30, 2017 | $142.87M | – |
| Q1 FY2017 | Mar 31, 2017 | $138.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $124.76M | – |
| Q3 FY2016 | Sep 30, 2016 | $120.30M | – |
See a number that looks wrong?